Oct
2026
Fiera Milano, Italy
Visit us
stand 4F97, API
Zone

Chengdu Shengnuo Biopharm Co., Ltd

Exhibitor at CPHI Milan 2026
About Us

Chengdu Shengnuo is one of the leading peptide manufacturers in China. There are 5 US-DMF of Peptide APIs:  Liraglutide, Bivalirudin, Eptifibatide, Icatibant and Octreotide. The below US-DMFs will be submitted soon: Linaclotide, Degarelix,  Teriparatide,Ziconotide,Exenatide and Ganirelix  soon. Shengnuo also have a few Chinese GMP APIs: Atosiban,Carbetocin, Octreotide, Enfuvirtide,Thymalfasin, Somatostatin, Thymopentin and Levosimendan.Chengdu Shengnuo Biopharm Co Ltd is a subsidiary of Chengdu Shengnuo Tech Development Co Ltd and was founded in October 2004. With 50 key technologies for large-scale production of domestic and foreign peptide drugs, we a...

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
View company profile
Contact info
  • 28-88202608
  • Website
  • Section 1, Gongye Avenue, Dayi County, 611330, Chengdu, Sichuan, China
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 4F97, API

Products Featured at CPHI Milan 2026

  • Bivalirudin

    Product Bivalirudin

     Use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty .Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, t...
  • Icatibant

    Product Icatibant

    is a synthetic peptidomimetic drug consisting of ten amino acids, and acts as an effective and specific antagonist of bradykinin B2 receptors. It has been approved in the EU for use in hereditary angioedema, and is under investigation for a number of other conditions in which bradykinin is thought to play ...
  • Liraglutide

    Product Liraglutide

    Diabetes mellitus, 
    Liraglutide is a once-daily GLP-1 derivative for the treatment of type 2 diabetesLabel,2. The prolonged action of liraglutide is achieved by attaching a fatty acid molecule at position 26 of the GLP-1 molecule, enabling it to bind reversibly to albumin within the subcutaneou...
  • Octreotide

    Product Octreotide

    Octreotide is the acetate salt of a cyclic octapeptide. It is a long-acting octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Prevention and treatment of acute pancreatitis and upper gastrointestinal bleeding, and can also be used for portal hypertension a...